The Journal of Clinical Psychiatry

Page 224

More JCP Articles

Educational Activity

Improving Patient Outcomes in Depression Through Guideline-Concordant, Measurement-Based Care

April 15, 2013

Larry Culpepper

Original Research

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer’s Disease: A Randomized, Placebo-Controlled Trial

April 3, 2013

Paul B. Rosenberg , Krista L. LanctÃ´t , Lea T. Drye , et al

Clinical and Practical Psychopharmacology

Antidepressant Action of Atypical Antipsychotics: Focus on Ziprasidone Monotherapy, With a Few Twists in the Tale

March 15, 2013

Chittaranjan Andrade

ASCP Corner

Reconsidering Chronic Hyponatremia in Psychosis

March 15, 2013

Richard C. Josiassen , Dawn M. Filmyer , Alexander G. Geboy , et al

Article

Teaching the Teacher: A Report From the Third Annual American Society of Clinical Psychopharmacology Teaching Session

March 15, 2013

Ira D. Glick , Sidney Zisook , Mark H. Rapaport

Original Research

Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone?

March 15, 2013

Nexhmedin Morina , Dean Ajdukovic , Marija Bogic , et al

Original Research

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

March 15, 2013

Gregory M. Asnis , Anjana Bose , Carl P. Gommoll , et al

Book Review

Essential CNS Drug Development

March 15, 2013

Ronald M. Salomon

Original Research

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

March 15, 2013

Jonathan P. Stange , Louisa G. Sylvia , Pedro Vieira da Silva Magalhães , et al

Article

Five-Year Course of Obsessive-Compulsive Disorder: Predictors of Remission and Relapse

March 15, 2013

Jane L. Eisen , Nicholas J. Sibrava , Christina L. Boisseau , et al

Article

Generalizability in Bipolar Treatment Trials

March 15, 2013

Read a full article on the generalizability in bipolar treatment and how they should carefully consider the impact of eligibility criteria.

Nicolas Hoertel , Yann Le Strat , Pierre Lavaud , et al

Book Review

Health Care Reform: A Primer for Psychiatrists

March 15, 2013

James H. Shore

« 1 … 222 223 224 225 226 … 758 »

Improving Patient Outcomes in Depression Through Guideline-Concordant, Measurement-Based Care

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer’s Disease: A Randomized, Placebo-Controlled Trial

Antidepressant Action of Atypical Antipsychotics: Focus on Ziprasidone Monotherapy, With a Few Twists in the Tale

Reconsidering Chronic Hyponatremia in Psychosis

Teaching the Teacher: A Report From the Third Annual American Society of Clinical Psychopharmacology Teaching Session

Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone?

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

Essential CNS Drug Development

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

Five-Year Course of Obsessive-Compulsive Disorder: Predictors of Remission and Relapse

Generalizability in Bipolar Treatment Trials

Health Care Reform: A Primer for Psychiatrists

ELSEWHERE:

FOLLOW US:

More JCP Articles

Improving Patient Outcomes in Depression Through Guideline-Concordant, Measurement-Based Care

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer’s Disease: A Randomized, Placebo-Controlled Trial

Antidepressant Action of Atypical Antipsychotics: Focus on Ziprasidone Monotherapy, With a Few Twists in the Tale

Reconsidering Chronic Hyponatremia in Psychosis

Teaching the Teacher: A Report From the Third Annual American Society of Clinical Psychopharmacology Teaching Session

Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone?

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

Essential CNS Drug Development

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

Five-Year Course of Obsessive-Compulsive Disorder: Predictors of Remission and Relapse

Generalizability in Bipolar Treatment Trials

Health Care Reform: A Primer for Psychiatrists

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles